Gilead Sciences, Inc. (GIS.F)

Frankfurt - Frankfurt Verzögerter Preis. Währung in EUR

Zur Watchlist hinzufügen

73,70

-0,20

(-0,27%)

Ab 04:24PM CET. Markt geöffnet.

Marktkap.	91,912B
Beta (5 J., monatlich)	0,40
Kurs-Gewinn-Verhältnis (roll. Hochrechn.)	21,49
EPS (roll. Hochrechn.)	N/A
Gewinndatum	N/A
Erwartete Dividende & Rendite	2,83 (3,78%)
Ex-Dividendendatum	14. März 2023
1-Jahres-Kursziel	N/A

Nachrichten

ACCESSWIRE
Gilead Sciences: A Career Rooted in Championing Diversity and Inclusion: Jesse's Story
NORHAMPTON, MA / ACCESSWIRE / November 10, 2022 / Gilead Sciences While Jesse Garcia was growing up in Chicago's inner city, his parents didn't immediately turn to a doctor when someone in the family got sick. "We relied on traditional Latino ...
ACCESSWIRE
Gilead's Path to Equitable Global COVID-19 Treatment Access
NORTHAMPTON, MA / ACCESSWIRE / November 2, 2022 / Gilead Sciences Since the beginning of the COVID-19 pandemic, Gilead's first-in-class antiviral was made available to more than 11 million patients globally- over 65% of whom live in low-and lower-middle-income ...
ACCESSWIRE
Gilead Sciences: Metastatic Breast Cancer Advocate Urges Black People to Join Clinical Trials
In the spring of 2018, North Carolina native Stephanie Walker went to her first breast cancer conference and had a revelation that she refers to as her "coming-out party." She learned she had metastatic breast cancer three years earlier and although she was a retired hospice nurse, she faced the disease without any guidance from others who shared her experience.